Orthologue chemical space and its influence on target prediction.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28961699.
- Also identified by DOI 10.1093/bioinformatics/btx525 and PMC identifier 5870859.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In silico approaches often fail to utilize bioactivity data available for orthologous targets due to insufficient evidence highlighting the benefit for such an approach. Deeper investigation into orthologue chemical space and its influence toward expanding compound and target coverage is necessary to improve the confidence in this practice. Here we present analysis of the orthologue chemical space in ChEMBL and PubChem and its impact on target prediction. We highlight the number of conflicting bioactivities between human and orthologues is low and annotations are overall compatible. Chemical space analysis shows orthologues are chemically dissimilar to human with high intra-group similarity, suggesting they could effectively extend the chemical space modelled. Based on these observations, we show the benefit of orthologue inclusion in terms of novel target coverage. We also benchmarked predictive models using a time-series split and also using bioactivities from Chemistry Connect and HTS data available at AstraZeneca, showing that orthologue bioactivity inclusion statistically improved performance. Orthologue-based bioactivity prediction and the compound training set are available at www.github.com/lhm30/PIDGINv2. ab454@cam.ac.uk. Supplementary data are available at Bioinformatics online.
Medical subject headings
- Computational Biology
- Computer Simulation
- Drug Discovery
- Proteins
- Sequence Homology, Amino Acid